Abstract:The distinct optical properties of surface-engineered quantum dots, featuring high fluorescent quantum yields and biocompatibility, render them valuable tools for precise and selective sensing and biosensing applications spanning diverse fields, including medicine, environmental monitoring, and diagnostics. In this study, we have successfully fabricated a new “OFF-ON” fluorescent probe based on 3-mercaptopropionic acid (MPA) - capped CdTe/ZnS QDs and neutral red (NR) for the determination of Naproxen (NAP) in pharmaceutical formulations and water samples. The as-prepared MPA-TGA-CdTe/ZnS QDs exhibit a robust photoluminescent emission, peaking at 544 nm upon excitation with a 380 nm wavelength. The quantum yield measurement for the TGA-CdTe QDs was ascertained to be 29.3 %. The findings displayed that the fluorescence emission of MPA-TGA-CdTe/ZnS quantum dots (QDs) could be significantly quenched by increasing neutral red concentration, which can be attributed to the formation of non-fluorescent NR- MPA-TGA-CdTe/ZnS QDs complex (NR-MPA energy level 1.15 Kcal/mol). Upon the addition of naproxen, there was a noticeable enhancement in fluorescence intensity because of the formation of the strong complex between naproxen and NR (NR-NAP energy level: −1.54 Kcal/mol), leading to the detachment of NR from the surface of quantum dots. Consequently, the MPA-TGA-CdTe/ZnS QDs became activated, resulting in the restoration of fluorescence intensity of MPA-TGA-CdTe/ZnS QDs. The enhancement of fluorescence intensity exhibited a direct relationship with the concentration of naproxen, following a linear trend within the concentration range of 2.00 × 10−1 to 27.3 µmol/L with the detection limits of 7.0 × 10−2 µmol/L. Moreover, computational studies were also used to validate the MPA-TGA-CdTe/ZnS QDs turn-off-ON sensor for sensing naproxen. The interactions of NAP, NR, and MPA-TGA-CdTe/ZnS QDs made a solid base for controlling the fluorescent reversibility of QDs. The as-prepared quantum dots were subjected to cytotoxicity studies using an MTT assay and AAS technique. These findings revealed that MPA-TGA-CdTe/ZnS QDs have greater biocompatibility and lower toxicity, making them attractive for biological applications. The recoveries of naproxen detection using the proposed fluorescent probe in various pharmaceutical formulations and water samples ranged from 97.4 % to 102 %, with a relative standard deviation of less than 5 %.

Highly sensitive and selective detection of naproxen via molecularly imprinted carbon dots as a fluorescent sensor

Efficient fluorescence probe for detection of naproxen in pharmaceutical formulations and water samples using MPA-capped CdTe/ZnS core-shell nanocrystal-neutral red: Experimental and computational studies

Development of a new chemically modified carbon paste electrode based on nano-sized molecular imprinted polymer for selective and sensitive determination of naproxen

Highly sensitive and label-free detection of naproxen using mixed metal oxide-based field effect transistor as a biosensor for in-vitro analysis of urine

Graphene-Oxide-Based Electrochemical Sensors for the Sensitive Detection of Pharmaceutical Drug Naproxen

Molecularly imprinted micelles for fluorescent sensing of nonsteroidal anti-inflammatory drugs (NSAIDs)

An ultrasensitive electrochemiluminescent immunosensor based on graphene oxide coupled graphite-like carbon nitride and multiwalled carbon nanotubes-gold for the detection of diclofenac.

A Novel Electrochemiluminescent Immunoassay for Diclofenac Using Conductive Polymer Functionalized Graphene Oxide As Labels and Gold Nanorods As Signal Enhancers.

Metal-Based Nanomaterials for the Sensing of NSAIDS

A new multifunctional electrocatalyst based on PbS nanostructures decorated with graphene/polyaniline-modified glassy carbon electrode for selective detection of non-steroidal anti-inflammatory drug naproxen

Ultrasensitive Detection of Diclofenac Based on Electrochemiluminescent Immunosensor with Multiple Signal Amplification Strategy of Palladium Attached Graphene Oxide As Bioprobes and Ceria Doped Zinc Oxide As Substrates

Highly sensitive and selective detection of amoxicillin using molecularly imprinted ratiometric fluorescent nanosensor based on quantum dots

Biomass-Derived Core-Shell Carbon Dots with Embedded Tripodal Receptors for the Selective Recognition of Mefenamic Acid in Pharmaceutical Formulations and Urine

A Novel Molecularly Imprinted Electrochemical Sensor Based on a Nitrogen-Doped Graphene Oxide Quantum Dot and Molybdenum Carbide Nanocomposite for Indometacin Determination

Highly sensitive electrochemical sensing of norfloxacin by molecularly imprinted composite hollow spheres

Highly Sensitive Determination of Diclofenac Based on Resin Beads and a Novel Polyclonal Antibody by Using Flow Injection Chemiluminescence Competitive Immunoassay.

Specific recognition and fluorescent determination of aspirin by using core-shell CdTe quantum dot-imprinted polymers

Lab-on-a-chip paper-based electrochemically assisted solid-phase microextraction and ion selective sensor for determination of naproxen in biological fluid samples

Novel manganese carbon quantum dots as a nano-probe: Facile synthesis, characterization and their application in naproxen delivery (Mn/CQD/SiO2@naproxen)

Surfactant-induced AIE-active tin(IV) micelles for sensing naproxen residues in pharmaceutical effluents

Synthesis and Characteristic of Molecularly Imprinted Polymer Immobilized Mesoporous Silica Sphere for Selective Binding of S-Naproxen